The risks of long term steroid therapy (therapy for more than 4 months and/or more than two courses in a year) outweigh any benefits in inflammatory bowel disease and should not be given to patients. Instead they should be offered more effective maintenance therapy such as immunosuppression or biologic therapy that are safer and have more evidence for efficacy.

Conditions: Inflammatory Bowel Disease (IBD)

Treatments: Steriod, Immunosuppression Therapy, Biologic Therapy